Gene Transfer Technologies Market Size, Strategic Analysis, Growth Drivers, Industry Trends, Demand and Future Opportunities and Forecast Period
The global gene transfer technologies market is
expected to develop at a compound annual growth rate (CAGR) of 9.7% from 2024
to 2034, from its estimated USD 3.63 billion in 2023 to USD 10.05 billion by
2034. Changing the genetic makeup of cells is the primary goal of gene transfer,
which is crucial for improving medical treatments, increasing agricultural
output, supporting scientific research, creating novel vaccines, customizing
healthcare solutions, and tackling environmental issues.
Request
For Free Sample Pages @ https://www.xresearch.biz/request-sample-pages/gene-transfer-technologies-market
GROWTH DRIVERS
Market demand is being largely impacted by the increased
prevalence of cancer and genetic abnormalities. The World Health Organization
estimates that in 2022, there will be 9.7 million cancer-related deaths
worldwide and 20 million new cases. The need for efficient gene treatments that
can treat the underlying genetic abnormalities or various forms of cancer is
growing as these conditions become more common.
One of the primary drivers of the gene transfer technology
market is the increasing demand for better cell and gene therapies as well as
personalized medicine. The goal of personalized medicine is to tailor treatment
to each patient's particular genetic profile, which frequently calls for
advanced gene transfer methods to
replace or alter damaged genes.
MARKET
SEGMENTATION:
By Product -
· Reagents,
Kits & Assays
· Consumables
· Instruments
· Other
Products
By Mode -
· Viral
Vectors
o Retroviruses
· Lentiviruses
· Other
Retroviruses
o Adenoviruses
o Adeno-Associated Viruses
o Other Viral Vectors
· Non-Viral
Vectors
o Chemical Methods
o Liposome-Mediated
o Calcium Phosphate
o DEAE-Dextran
o Cationic Polymers
o Other Chemical Methods
· Physical
Methods
o Electroporation
o Microinjection
o Gene Guns
o Other Physical Methods
By Method -
· In-Vivo
· Ex-Vivo
· In-Vitro
By Application -
· Therapeutic
Applications
o Gene Therapy
o Cell Therapy
o Vaccines
o Other Therapeutic Applications
· Research
Applications
o Drug Discovery & Development
o Infectious Diseases
o Genetic & Neurological
Disorders
o Autoimmune Diseases
o Other Diseases
o Other Research Applications
· Other
Applications
By End User -
· Pharmaceutical
& Biotechnology Companies
· Academic
& Research Institutes
· Other
End Users
By Region -
· North
America
· Europe
· Asia
Pacific
· Latin
America
· Middle
East & Africa
Key Players:
· Thermo
Fisher Scientific Inc.
· Danaher
Corporation
· Merck
KGaA
· Qiagen
· Sartorius
AG
· Bio-Rad
Laboratories Inc.
· Revvity,
Inc.
· GenScript
· Takara
Bio Inc.
· Promega
Corporation
· Other
Key & Niche Players
For
More Information about this Report @ https://www.xresearch.biz/shop/gene-transfer-technologies-market
About
Us: -
xResearch is a
market research and consulting organization that uses unique data, expert
analysis, and new technologies to create trusted intelligence on industries.
Our research is focused on delivering an informed and impartial view on
essential market data of industry, and it is primarily driven by an in-depth
study covering the following parameters: Market Sizing and Forecasting, Market
Segmentation, Competitive Analysis, Strategic Assessment and Business
Modelling.
Contact:
Company Name: xResearch
Contact Person: James Lin
Email: sales@xresearch.biz
Phone: +1 718-619-8140
Websites:
https://www.xresearch.biz/

Comments
Post a Comment